Dermsquared

Obesity and psoriasis are connected by inflammation, not just coincidence. GLP-1 RAs are reshaping how we manage both.

Join us at PANP360 West in Scottsdale for ‘Collaborative Conversations on GLP-1 Receptor Agonists in Psoriasis Management,’ led by Chair Karan Lal, DO, MS, FAAD, alongside Angela Fitch, MD, FACP, MFOMA, Henry Yu, PA-C, and Patient Advocate Kerrie Linn, expect a fast-paced didactic followed by four rotating case stations. Real patients. Real side effects. Real conversations on what's actually working in practice.

Sunday, May 31, 2026 | 9:00 AM-10:00 AM MST | Scottsdale, AZ

What you'll take away:
-How GLP-1 RA therapy intersects with obesity and psoriasis (PsO) severity
-Practical guidance on therapy selection, counseling, and combination strategies
-Expert-driven approaches to the patient questions that come up most

Earn up to 1.0 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵(𝘴)™.

This activity is supported by an educational grant from Lilly.

Can’t make it to Scottsdale? There’s still time to register virtually at: https://bit.ly/3PFv7no

This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared®. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Nevada, Reno School of Medicine designates this live activity for a maximum of 1.0 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵(𝘴)™. Physicians should claim only the credit commensurate with the extent of their participation in each activity.